Active Ingredient(s):Olopatadine Hydrochloride + Mometasone Furoate Monohydrate FDA Approved: * January 13, 2022 Pharm Company: *GLENMARK SPECIALTY SA Category:Allergies, Cough & Cold
Olopatadine/mometasone, sold under the brand name Ryaltris, is a fixed-dose combination medication for the treatment of allergic rhinitis and rhinoconjunctivitis in adults and adolescents twelve years of age and older. It contains olopatadine hydrochloride and mometasone furoate monohydrate. It is sprayed into the nose.
Common side effects include an unpleasant ...
* May have multiple approval dates, manufacturers, or labelers.